Sihoun Hahn, M.D.
Copper transport disorders
and mitochondrial disorders.
His work is focused on developing newborn screening which uses tandem mass spectrometry for Wilson's disease, a genetic disease in which the body cannot excrete copper properly, leading to its accumulation in various organs including the liver and brain. He is developing an assay that quickly determines if the mitochondrial disease is present. He hopes to improve clinical practice through integrated laboratory testing and true translational research.
English, Korean
Genetics
| Korea University, College of Medicine |
Medical education |
1983 |
| Korea University Guro Hospital |
Internship |
|
| Korea University Guro Hospital |
Residency |
|
| Korea University Graduate School |
Ph.D |
1995 |
| National Institutes of Health |
Fellowship |
|
| American Board of Medical Genetics |
Clinical Biochemical Genetics |
1999 |
| American Board of Medical Genetics |
Clinical Genetics |
1999 |
| Year | Name |
| 2009 | Luminex / American College of Medical Genetics Foundation (ACMGF) Award |
Searching for Publications, Please Wait . . .
|